Probing for a deeper understanding of rhabdomyosarcoma: Insights from complementary model systems

Venkatesh P. Kashi, Mark E. Hatley, Rene L. Galindo

Research output: Contribution to journalReview articlepeer-review

60 Scopus citations

Abstract

Rhabdomyosarcoma (RMS) is a mesenchymal malignancy composed of neoplastic primitive precursor cells that exhibit histological features of myogenic differentiation. Despite intensive conventional multimodal therapy, patients with high-risk RMS typically suffer from aggressive disease. The lack of directed therapies against RMS emphasizes the need to further uncover the molecular underpinnings of the disease. In this Review, we discuss the notable advances in the model systems now available to probe for new RMS-targetable pathogenetic mechanisms, and the possibilities for enhanced RMS therapeutics and improved clinical outcomes.

Original languageEnglish (US)
Pages (from-to)426-439
Number of pages14
JournalNature Reviews Cancer
Volume15
Issue number7
DOIs
StatePublished - Jul 26 2015

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Probing for a deeper understanding of rhabdomyosarcoma: Insights from complementary model systems'. Together they form a unique fingerprint.

Cite this